Method for improving apparent catalytic activity of glutamic acid decarboxylase recombinant engineering bacteria
A technology of glutamic acid decarboxylase and recombinant engineering bacteria, applied in the direction of microorganism-based methods, biochemical equipment and methods, and adding compounds to stimulate growth, etc., can solve the problem of increasing production costs, increasing multi-step process steps, and large-scale Unfavorable production and other problems, to achieve the effect of vigorous growth, low sensitivity, avoiding investment in steps and related equipment operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0030] Pick the monoclonal cells from the activated LB solid medium and insert into 5mL containing kanamycin (50μg·mL -1 ) in LB liquid medium at 37°C with 200r / min shaking overnight to obtain seed liquid. The seed solution was inoculated into the seed solution containing kanamycin (50 μg·mL) according to the volume fraction of 1% inoculum -1 ) in LB medium, cultured at 37°C, 200r / min until OD 600 Add IPTG at 0.6-0.8, so that the final concentration of IPTG is 0.5μM, and at the same time add the final concentration of 3μg·mL -1 ampicillin, 30°C, 150r / min induction culture for 6h. At the same time, cultured cells without ampicillin were used as blank control.
[0031]After the cultivation, a certain amount of bacterial liquid was collected at 4°C and centrifuged at 10,000 g for 5 minutes to collect the bacterial cells, and the bacterial cells were washed once with 200 mM acetic acid buffer (pH 4.8), and the apparent catalytic activity of the bacterial cells was determined t...
Embodiment 2
[0033] Pick the monoclonal cells from the activated LB solid medium and insert into 5mL containing kanamycin (50μg·mL -1 ) in LB liquid medium at 37°C with 200r / min shaking overnight to obtain seed liquid. The seed solution was inoculated into the seed solution containing kanamycin (50 μg·mL) according to the volume fraction of 1% inoculum -1 ) in LB medium, cultured at 37°C, 200r / min until OD 600 Add IPTG at 0.6-0.8, so that the final concentration of IPTG is 0.5μM, and at the same time add the final concentration of 5μg·mL -1 ampicillin, 30°C, 150r / min induction culture for 6h. At the same time, cultured cells without ampicillin were used as blank control.
[0034] After the cultivation, a certain amount of bacterial liquid was collected at 4°C and centrifuged at 10,000 g for 5 minutes to collect the bacterial cells, and the bacterial cells were washed once with 200 mM acetate buffer (pH 4.8), and the apparent catalytic activity of the bacterial cells was determined to b...
Embodiment 3
[0036] Pick the monoclonal cells from the activated LB solid medium and insert into 5mL containing kanamycin (50μg·mL -1 ) in LB liquid medium at 37°C with 200r / min shaking overnight to obtain seed liquid. The seed solution was inoculated into the seed solution containing kanamycin (50 μg·mL) according to the volume fraction of 1% inoculum -1 ) in LB medium, cultured at 37°C, 200r / min until OD 600 Add IPTG at 0.6-0.8, so that the final concentration of IPTG is 0.5μM, and at the same time add the final concentration of 10μg·mL -1 CTAB, 30°C, 150r / min induction culture for 6h. At the same time, the cultured cells without CTAB were used as blank control.
[0037] After the cultivation, a certain amount of bacterial liquid was collected at 4°C and centrifuged at 10,000 g for 5 minutes to collect the bacterial cells, washed with 200 mM acetic acid buffer (pH 4.8) once, and the apparent catalytic activity of the bacterial cells was measured to be 1.40 U / mg. Compared with the ba...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com